149 related articles for article (PubMed ID: 32464648)
21. Antithrombotic strategies after interventional left atrial appendage closure: an update.
Chen S; Weise FK; Chun KRJ; Schmidt B
Expert Rev Cardiovasc Ther; 2018 Sep; 16(9):675-678. PubMed ID: 30095350
[TBL] [Abstract][Full Text] [Related]
22. Effectiveness of Only Aspirin or Clopidogrel Following Percutaneous Left Atrial Appendage Closure.
Pouru JP; Jaakkola S; Lund J; Biancari F; Saraste A; Airaksinen KEJ
Am J Cardiol; 2019 Dec; 124(12):1894-1899. PubMed ID: 31668344
[TBL] [Abstract][Full Text] [Related]
23. Real-world safety and efficacy of WATCHMAN LAA closure at one year in patients on dual antiplatelet therapy: results of the DAPT subgroup from the EWOLUTION all-comers study.
Bergmann MW; Ince H; Kische S; Schmitz T; Meincke F; Schmidt B; Foley D; Betts TR; Grygier M; Protopopov AV; Stein KM; Boersma LVA
EuroIntervention; 2018 Apr; 13(17):2003-2011. PubMed ID: 29313819
[TBL] [Abstract][Full Text] [Related]
24. Antithrombotic strategies after transcatheter aortic valve implantation: Insights from a network meta-analysis.
Kuno T; Takagi H; Sugiyama T; Ando T; Miyashita S; Valentin N; Shimada YJ; Kodaira M; Numasawa Y; Kanei Y; Hayashida K; Bangalore S
Catheter Cardiovasc Interv; 2020 Aug; 96(2):E177-E186. PubMed ID: 31609071
[TBL] [Abstract][Full Text] [Related]
25. Safety and Efficacy of Single Versus Dual Antiplatelet Therapy After Left Atrial Appendage Occlusion.
Patti G; Sticchi A; Verolino G; Pasceri V; Vizzi V; Brscic E; Casu G; Golino P; Russo V; Rapacciuolo A; Boccuzzi G; Mangieri A; Pagnotta PA; Colombo A;
Am J Cardiol; 2020 Nov; 134():83-90. PubMed ID: 32892987
[TBL] [Abstract][Full Text] [Related]
26. Stand-Alone Thoracoscopic Left Atrial Appendage Closure in Nonvalvular Atrial Fibrillation Patients at High Bleeding Risk.
Franciulli M; De Martino G; Librera M; Desoky A; Mariniello A; Iavazzo A; Scigliano F; Esposito G; Chiariello L
Innovations (Phila); 2020; 15(6):541-546. PubMed ID: 33048625
[TBL] [Abstract][Full Text] [Related]
27. Antithrombotic therapy after left atrial appendage closure.
Schmidt B; Chun KR
Expert Rev Cardiovasc Ther; 2015 Jan; 13(1):105-9. PubMed ID: 25434598
[TBL] [Abstract][Full Text] [Related]
28. Dual antiplatelet therapy after percutaneous left atrial appendage occlusion: single center experience with the Amplatzer Cardiac Plug.
Bertrand PB; Habran M; Kenis K; Lecomte J; Moonen L; Stroobants D; Benit E
Acta Cardiol; 2019 Feb; 74(1):74-81. PubMed ID: 29607737
[TBL] [Abstract][Full Text] [Related]
29. Incidence, predictors and outcomes of device-related thrombus after left atrial appendage closure with the WATCHMAN device-Insights from the EWOLUTION real world registry.
Sedaghat A; Nickenig G; Schrickel JW; Ince H; Schmidt B; Protopopov AV; Betts TR; Gori T; Sievert H; Mazzone P; Grygier M; Wald C; Vireca E; Allocco D; Boersma LVA;
Catheter Cardiovasc Interv; 2021 Jun; 97(7):E1019-E1024. PubMed ID: 33417282
[TBL] [Abstract][Full Text] [Related]
30. Left Atrial Appendage Closure Versus Direct Oral Anticoagulants in High-Risk Patients With Atrial Fibrillation.
Osmancik P; Herman D; Neuzil P; Hala P; Taborsky M; Kala P; Poloczek M; Stasek J; Haman L; Branny M; Chovancik J; Cervinka P; Holy J; Kovarnik T; Zemanek D; Havranek S; Vancura V; Opatrny J; Peichl P; Tousek P; Lekesova V; Jarkovsky J; Novackova M; Benesova K; Widimsky P; Reddy VY;
J Am Coll Cardiol; 2020 Jun; 75(25):3122-3135. PubMed ID: 32586585
[TBL] [Abstract][Full Text] [Related]
31. Safety and efficacy of different anticoagulation regimens after left atrial appendage occlusion.
Li W; Gao R; Zhao J; Ren Y; Chen G; Zhu J; Jin K; Zhu L; Ruan Z
Ann Palliat Med; 2022 Jan; 11(1):201-209. PubMed ID: 35144411
[TBL] [Abstract][Full Text] [Related]
32. Left atrial appendage closure with the Watchman device in patients with a contraindication for oral anticoagulation: the ASAP study (ASA Plavix Feasibility Study With Watchman Left Atrial Appendage Closure Technology).
Reddy VY; Möbius-Winkler S; Miller MA; Neuzil P; Schuler G; Wiebe J; Sick P; Sievert H
J Am Coll Cardiol; 2013 Jun; 61(25):2551-6. PubMed ID: 23583249
[TBL] [Abstract][Full Text] [Related]
33. Initial Experience With High-Risk Patients Excluded From Clinical Trials: Safety of Short-Term Anticoagulation After Left Atrial Appendage Closure Device.
Barakat AF; Hussein AA; Saliba WI; Bassiouny M; Tarakji K; Kanj M; Jaber W; Rodriguez LL; Grimm R; Hussain MS; Russman A; Uchino K; Wisco D; Rasmussen P; Bain M; Vargo J; Zuccaro G; Gottesman D; Lindsay BD; Wazni OM
Circ Arrhythm Electrophysiol; 2016 Jun; 9(6):. PubMed ID: 27225288
[TBL] [Abstract][Full Text] [Related]
34. Short-Term Oral Anticoagulation Versus Antiplatelet Therapy Following Transcatheter Left Atrial Appendage Closure.
Asmarats L; O'Hara G; Champagne J; Paradis JM; Bernier M; O'Connor K; Beaudoin J; Junquera L; Del Val D; Muntané-Carol G; Côté M; Rodés-Cabau J
Circ Cardiovasc Interv; 2020 Aug; 13(8):e009039. PubMed ID: 32772571
[TBL] [Abstract][Full Text] [Related]
35. Thromboembolic events and need for anticoagulation therapy following left atrial appendage occlusion in patients with electrical isolation of the appendage.
Gadiyaram VK; Mohanty S; Gianni C; Trivedi C; Al-Ahmad A; Burkhardt DJ; Gallinghouse JG; Hranitzky PM; Horton RP; Sanchez JE; Della Rocca DG; Di Biase L; Price MJ; Couts L; Gibson D; Natale A
J Cardiovasc Electrophysiol; 2019 Apr; 30(4):511-516. PubMed ID: 30623500
[TBL] [Abstract][Full Text] [Related]
36. Propensity-matched comparison of antiplatelet versus anticoagulant after left atrial appendage closure with the Watchman.
Liu XX; Kleinecke C; Busch S; Allakkis W; Mohrez Y; Cheikh-Ibrahim M; Mahnkopf C; Brachmann J; Schnupp S; Gloekler S; Yu J; Ma C
Pacing Clin Electrophysiol; 2020 Nov; 43(11):1242-1251. PubMed ID: 32779203
[TBL] [Abstract][Full Text] [Related]
37. Clinical Results of Left Atrial Appendage Closure with Watchman Device in Patients with Atrial Fibrillation.
Pheerawong P; Songmuang SB; Lertsuwunseri V; Satitthummanid S; Srimahachota S
J Med Assoc Thai; 2015 Oct; 98(10):942-9. PubMed ID: 26638585
[TBL] [Abstract][Full Text] [Related]
38. Short-term direct oral anticoagulation or dual antiplatelet therapy following left atrial appendage closure in patients with relative contraindications to chronic anticoagulation therapy.
Faroux L; Cruz-González I; Arzamendi D; Freixa X; Nombela-Franco L; Peral V; Caneiro-Queija B; Mangieri A; Trejo-Velasco B; Asmarats L; Regueiro A; McInerney A; Mas-Lladó C; Estevez-Loureiro R; Laricchia A; O'Hara G; Rodés-Cabau J
Int J Cardiol; 2021 Jun; 333():77-82. PubMed ID: 33647365
[TBL] [Abstract][Full Text] [Related]
39. The WATCHMAN left atrial appendage closure device for patients with atrial fibrillation: current status and future perspectives.
Wintgens LIS; Maarse M; Swaans MJ; Rensing BJWM; Van Dijk VF; Boersma LVA
Expert Rev Med Devices; 2020 Jul; 17(7):615-626. PubMed ID: 32543911
[TBL] [Abstract][Full Text] [Related]
40. Device-Related Thrombosis After Percutaneous Left Atrial Appendage Occlusion for Atrial Fibrillation.
Fauchier L; Cinaud A; Brigadeau F; Lepillier A; Pierre B; Abbey S; Fatemi M; Franceschi F; Guedeney P; Jacon P; Paziaud O; Venier S; Deharo JC; Gras D; Klug D; Mansourati J; Montalescot G; Piot O; Defaye P
J Am Coll Cardiol; 2018 Apr; 71(14):1528-1536. PubMed ID: 29622159
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
